Impact of ABO-Incompatible Donor on Early and Late Outcome of Hematopoietic Stem Cell Transplantation

Transplantation Proceedings

Volumn 41, Issue 9, 2009, Pages 3851-3858

  Ozkurt, Z N ^a   Yegin, Z A ^a   Yenicesu, I ^a   Aki, S Z ^a   Yagci, M ^a   Sucak, G T ^a  

^a GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FERRITIN; FLUDARABINE; MELPHALAN; METHOTREXATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; ARTICLE; BLOOD COMPATIBILITY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; CHOLESTASIS; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DISEASE SEVERITY; ENGRAFTMENT; ERYTHROCYTE TRANSFUSION; FEMALE; FERRITIN BLOOD LEVEL; GRAFT INFECTION; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HODGKIN DISEASE; HOSPITAL DISCHARGE; HUMAN; HYPERFERRITINEMIA; IRON CHELATION; IRON OVERLOAD; LIVER SINUSOID; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUCOSA INFLAMMATION; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; ORGAN DONOR; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PURE RED CELL ANEMIA; RECURRENCE RISK; THROMBOCYTE TRANSFUSION; TRANSPLANT RELATED MORTALITY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD GROUP INCOMPATIBILITY; FEMALE; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 71749098195     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.189     Document Type: Article

References (53)

1. Seebach J.D., Stussi G., Passweg J.R., et al. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biol Blood Marrow Transplant 11 (2005) 1006
2. Klumpp T.R. Immunohematological complications of bone marrow transplantation. Bone Marrow Transplant 8 (1991) 159
3. Benjamin R.J., McGurk S., Ralston M.S., et al. ABO incompatibility as an adverse risk factor for survival after allogeneic bone marrow transplantation. Transfusion 39 (1999) 179
4. Stussi G., Muntwyler J., Passweg J.R., et al. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 30 (2002) 87
5. Kim J.G., Sohn S.K., Kim D.H., et al. Impact of ABO incompatibility on outcome after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 35 (2005) 489
6. Goldman J., Liesveld J., Nichols D., et al. ABO incompatibility between donor and clinical outcomes in allogeneic stem cell transplantation. Leuk Res 27 (2003) 489
7. Klump T.R., Herman J.H., Ulicny J., et al. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 38 (2006) 615
8. Rozman P., Kosir A., and Bohinjec M. Is the ABO incompatibility a risk factor in bone marrow transplantation?. Transpl Immunol 14 (2005) 159
9. Canals C., Muniz-Diaz E., Martinez C., et al. Impact of the ABO incompatibility on allogeneic peripheral blood progenitor cell transplantation after reduced intensity conditioning. Transfusion 44 (2004) 1603
10. Buckner C.D., Clift R.A., Sanders J.E., et al. ABO incompatible marrow transplants. Transplantation 26 (1978) 233
11. Bensinger W.I., Buckner C.D., Thomas E.D., et al. ABO incompatible marrow transplants. Transplantation 33 (1982) 427
12. Raimondi R., Soli M., Lamparelli T., et al. ABO-incompatible bone marrow transplantation: a GITMO survey of current practice in Italy and comparison with the literature. Bone Marrow Transplant 34 (2004) 321
13. Kimura F., Sato K., Kobayashi S., et al. Impact of ABO-blood group incompatibility on the outcome of recipients of bone marrow transplants from unrelated donors in the Japan Marrow Donor Program. Haematologica 93 (2008) 1686
14. Worel N., Kalhs P., Keil F., et al. ABO mismatch increases transplant-related morbidity and mortality in patients given nonmyeloablative allogeneic HPC transplantation. Transfusion 43 (2003) 1153
15. Majhail N.S., Lazarus H.M., and Burns L.J. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 41 (2008) 997
16. Armand P., Kim H.T., Cutler C.S., et al. Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood 109 (2007) 4586
17. Ho G.T., Parker A., MacKenzie J.F., et al. Abnormal liver function tests following bone marrow transplantation: aetiology and role of liver biopsy. Eur J Gastroenterol Hepatol 16 (2004) 157
18. Tomas J.F., Pinilla I., Garcia-Buey M.L., et al. Long term liver dysfunction after allogeneic bone marrow transplantation: clinical features and course in 61 patients. Bone Marrow Transplant 26 (2000) 649
19. Sucak G.T., Yegin Z.A., Ozkurt Z.N., et al. The role of liver biopsy in the workup of liver dysfunction late after SCT: is the role of iron overload underestimated?. Bone Marrow Transplant 42 (2008) 461
20. Oliveri N.F., Brittenham G.M., Me Larren C.E., et al. Long-term safety and effectiveness of iron-chelation therapy with deferripirone for thalassemia major. N Engl J Med 339 (1998) 417
21. Rowley S.D. Hematopoietic stem cell transplantation between red cell incompatible donor-recipient pairs. Bone Marrow Transplant 28 (2001) 315
22. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825
23. Sullivan K.M. Graft-versus host disease. In: Thomas E.D., Blume K.G., and Forman S.J. (Eds). Hematopoietic Cell Transplantation. 2nd ed. (1999), Blackwell Science, Oxford 515
24. McDonald G.B., Hinds M.S., Fisher L.D., et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Ann Intern Med 118 (1993) 255
25. Helbig G., Stella-Holowiecka B., Wojnar J., et al. Pure red-cell aplasia following major bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different strategies. Ann Hematol 86 (2007) 677
26. Lee J.H., Lee K.H., Kim S., et al. Anti-A isoagglutinin as a risk factor for the development of pure red cell aplasia after major ABO-incompatible allogeneic bone marrow transplantation. Bone Marrow Transplant 25 (2000) 179
27. Stussi G., Huggel K., Schanz U., et al. Levels of anti-A/B antibodies after ABO-incompatible hematopoietic stem cell transplantation. Transplant Proc 37 (2005) 1385
28. Bolan C.D., Leitman S.F., Griffith L.M., et al. Delayed donor red cell chimerism and pure red cell aplasia following major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation. Blood 98 (2001) 1687
29. Domadar S., George B., Mathews V., et al. Pre-transplant reduction of isohaemagglutinin titres by donor group plasma infusion does not reduce the incidence of pure red cell aplasia in major ABO-mismatched transplants. Bone Marrow Transplant 36 (2005) 233
30. Worel N., Greinix H.T., Schneider B., et al. Regeneration of erythropoesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems. Transfusion 40 (2000) 543
31. Worel N., Greinix H.T., Keil F., et al. Severe immune hemolysis after minor incompatible allogeneic peripheral blood stem cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning. Transfusion 42 (2002) 1293
32. Bolan C.D., Childs R.W., Procter J.L., et al. Massive immune hemolysis after allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility. Br J Haematol 112 (2001) 787
33. Helming A.M., Brand A., Wolterbeek R., et al. ABO incompatible stem cell transplantation in children does not influence outcome. Pediatr Blood Cancer 49 (2007) 313
34. Remberger M., Watz E., Ringdén O., et al. Major ABO blood group mismatch increases the risk for graft failiure after unrelated donor hematopoetic stem cell transplantation. Biol Blood Marrow Transplant 13 (2007) 675
35. Rose C., Ernst O., Hecquet B., et al. Quantification by magnetic resonance imaging and liver consequences of post-transfusional iron overload alone in long-term survivors after allogeneic hematopoietic stem cell transplantation. Hematologica 92 (2007) 850
36. Lapierre V., Mahé C., Aupérin A., et al. Platelet transfusion containing ABO-incompatible plasma and hepatic veno-occlusive disease after hematopoietic transplantation in young children. Transplantation 80 (2005) 314
37. Mielcarek M., Leisenring W., Torok-Storb B., et al. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect. Blood 96 (2000) 1150
38. Mehta J., Powles R., Sirohi B., et al. Does donor recipient ABO incompatibility protect against relapse after allogeneic bone marrow transplantation in first remission acute leukaemia?. Bone Marrow Transplant 29 (2002) 853
39. Kalaycioglu M., Copelan E., Avalos B., et al. Survival after ABO-incompatible allogeneic bone marrow transplant after a preparative regimen of busulfan and cyclophosphamide. Bone Marrow Transplant 15 (1995) 105
40. Bacigalupo A., Van Lint M.T., Occhini D., et al. ABO compatibility and acute graft versus host disease following allogeneic bone marrow transplantation. Transplantation 45 (1988) 1091
41. Biedermann B.C., Sahner S., Gregor M., et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359 (2002) 2078
42. Matsui B.T., Shimoyama T., Matsumoto M., et al. ABO blood group antigens an human plasma von Willebrand factor after ABO-mismatched bone marrow transplantation. Blood 94 (1999) 2895
43. Eiz-Vesper B., Seltsam A., and Blasczyk R. ABO glycosyltransferases as potential source of minor histocompatibility antigens in allogeneic peripheral blood progenitor cell transplantation. Transfusion 45 (2005) 960
44. Kataoka K., Nannya Y., Hangaishi A., et al. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoetic stem cell transplantation. Biol Blood Marrow Transplant 15 (2009) 195
45. Resnick I.B., Tsirigotis P.D., Shapira M.Y., et al. ABO incompatibility is associated with increased non-relapse and GVHD related mortality in patients with malignancies treated with a reduced intensity regimen: a single center experience of 221 patients. Biol Blood Marrow Transplant 14 (2008) 409
46. Benjamin R.J., and Antin J.H. ABO-incompatible bone marrow transplantation: the transfusion of incompatible plasma may exacerbate regimen related toxicity. Transfusion 39 (1999) 1273
47. Michallet M., Le Q.H., Mohty M., et al. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for haematological malignancies: a 10 year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie. Exp Hematol 36 (2008) 535
48. Rowley S.D., Liang P.S., and Ulz L. Transplantatation of ABO incompatible bone marrow and peripheral stem cell components. Bone Marrow Transplant 26 (2000) 749
49. Kanda J., Ichinohe T., Matsuo K., et al. lmpact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies. IPD-based meta-analysis of cohort studies. Transfusion 49 (2009) 624
50. John M.A., Rhemtula Y.A., Menezes C.N., et al. Lamivudine induced red cell aplasia. J Med Microbiol 57 (2008) 1032
51. Majluf-Cruz A., Luna Castaňos G., Treviňo-Pěrez S., et al. Lamivudine-induced pure red cell aplasia. Am J Hematol 65 (2000) 189
52. Kim D.H., Sohn S.K., Jeon S.B., et al. Prognostic significance of platelet recovery pattern after allogeneic HLA-identical sibling transplantation and its association with svere acute GVHD. Bone Marrow Transplant 37 (2006) 101
53. Bolwell B., Pohlman B., Sobecks R., et al. Prognostic importance of the platelet count 100 days post allogeneic bone marrow transplant. Bone Marrow Transplant 3 (2004) 419